What hypofractionated protocols should be tested for prostate cancer?
- 15 July 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (4) , 1093-1104
- https://doi.org/10.1016/s0360-3016(03)00132-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Is the α/β for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021–1031International Journal of Radiation Oncology*Biology*Physics, 2002
- The prospects for new treatments for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissueInternational Journal of Radiation Oncology*Biology*Physics, 2002
- A simple analytic derivation suggests that prostate cancer α/β ratio is lowInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Toward optimal external-beam fractionation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Is the prostate α/β ratio of 1.5 from Brenner & Hall a modeling artifact?International Journal of Radiation Oncology*Biology*Physics, 2000
- In response to Drs. King and Mayo: low α/β values for prostate appear to be independent of modeling detailsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999